Marinus Pharmaceuticals | MRNS - Przychody Ze Sprzedaży



Obroty Zmiana Data
Acadia Pharmaceuticals USD 284M 5.4M 2025-12
ALKERMES USD 384.5M 9.7M 2025-12
Amgen USD 9.9B 340M 2025-12
Biogen USD 2.28B 250M 2025-12
Eisai JPY 219.94B 22.58B 2025-12
Enanta Pharmaceuticals USD 16.96M 50.68M 2024-12
Esperion Therapeutics USD 51.63M 22.2M 2024-09
Gilead Sciences USD 7.93B 130M 2025-12
Incyte USD 1.51B 140M 2025-12
Minerva Neurosciences USD 0 0 2024-09
Neurocrine Biosciences USD 805.5M 10.6M 2025-12
PTC Therapeutics USD 164.7M 46.3M 2025-12
Regeneron Pharmaceuticals USD 3.88B 130M 2025-12
Sarepta Therapeutics USD 442.9M 43.5M 2025-12
Supernus Pharmaceuticals USD 211.6M 19.5M 2025-12
UCB EUR 3.49B 129M 2025-06
Vertex Pharmaceuticals USD 3.19B 110M 2025-12